Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid Tumors
Clinical trial NCT00069277 · COMPLETED
Trial details
- NCT number
- NCT00069277
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2005-04-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.